APA (7th ed.) Citation

Kiran Godse. (2017). Secukinumab - first in class interleukin-17A inhibitor for the treatment of psoriasis. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Kiran Godse. Secukinumab - First in Class Interleukin-17A Inhibitor for the Treatment of Psoriasis. Wolters Kluwer Medknow Publications, 2017.

MLA (9th ed.) Citation

Kiran Godse. Secukinumab - First in Class Interleukin-17A Inhibitor for the Treatment of Psoriasis. Wolters Kluwer Medknow Publications, 2017.

Warning: These citations may not always be 100% accurate.